Bacterial vaginosis epidemiology and demographics

Revision as of 19:29, 13 September 2017 by Mmir (talk | contribs)
Jump to navigation Jump to search

Sexually transmitted diseases Main Page

Vaginitis Main Page

Bacterial vaginosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Bacterial vaginosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Amsel Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bacterial vaginosis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bacterial vaginosis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bacterial vaginosis epidemiology and demographics

CDC on Bacterial vaginosis epidemiology and demographics

Bacterial vaginosis epidemiology and demographics in the news

Blogs on Bacterial vaginosis epidemiology and demographics

Directions to Hospitals Treating Bacterial vaginosis

Risk calculators and risk factors for Bacterial vaginosis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

Bacterial vaginosis is the most common cause of vaginal symptoms among women; it is not clear what role sexual activity plays in the development of BV. The prevalence of BV in the United States is estimated to be 21.2 million (29.2%) among women ages 14–49.[1]

Epidemiology

Bacterial vaginosis is the most common cause of vaginal symptoms among women, but it is not clear what role sexual activity plays in the development of BV. The prevalence in the United States is estimated to be 21.2 million (29.2%) among women ages 14–49.

Prevalence

A 2013 systematic review reported that BV prevalence varies between and within countries worldwide.[2][3]

  • In South and East Africa, higher rates of BV were estimated (68% in Mozambique, 51% in Lesotho, 44% in Kenya, 37% in Gambia)
  • In Southeast Asia, Australia, New Zealand, and Indonesia, the rates of BV were typically greater than 30%
  • In Norway (24%), Turkey (23%), and Poland (19%), women have moderately high BV rates
  • In Latin America and the Caribbean, lower rates of BV were estimated, except in rural and antenatal populations in Jamaica and Peru (~40%)

Race

The prevalence of bacterial vaginosis varies by race/ethnicity:[4]

  • African-American (51%)
  • Hispanic (32%)
  • Whites (23%)

Associated condition

Pregnancy

  • As many as one-third of all pregnant women in the United States have bacterial vaginosis.

Life time sexual partners

The prevalence of BV is associated with lifetime number of sexual partners:[5]

  • The prevalence of bacterial vaginosis among women with more than one sex partner in the previous 12 months (recent) and more than one lifetime sex partner was estimated to be 39.6%
  • The prevalence of bacterial vaginosis among women with no or one recent sex partner and more than one lifetime partner was estimated to be 29.1%
  • The prevalence of bacterial vaginosis among women with no or one sex partner in the last 12 months and one lifetime partner was estimated to be 22.4%
  • The prevalence of bacterial vaginosis among women who never had sex was estimated to be 18.8%

HIV Infection

The prevalence of bacterial vaginosis is reportedly high among HIV-positive and infertile women.[6]

References

  1. Centers for Disease Control and Prevention. Bacterial Vaginosis (BV) Statisticshttp://www.cdc.gov/std/bv/stats.htm Accessed on October 18, 2016
  2. Nugent RP, Krohn MA, Hillier SL (1991). "Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation". J Clin Microbiol. 29 (2): 297–301. PMC 269757. PMID 1706728.
  3. Kenyon C, Colebunders R, Crucitti T (2013). "The global epidemiology of bacterial vaginosis: a systematic review". Am J Obstet Gynecol. 209 (6): 505–23. doi:10.1016/j.ajog.2013.05.006. PMID 23659989.
  4. Yen S, Shafer MA, Moncada J, Campbell CJ, Flinn SD, Boyer CB (2003). "Bacterial vaginosis in sexually experienced and non-sexually experienced young women entering the military". Obstet Gynecol. 102 (5 Pt 1): 927–33. PMID 14672465.
  5. The Prevalence of Bacterial Vaginosis in the United States, 2001–2004; Associations With Symptoms, Sexual Behaviors, and Reproductive Health. http://journals.lww.com/stdjournal/Fulltext/2007/11000/The_Prevalence_of_Bacterial_Vaginosis_in_the.6.aspx#
  6. Lallar M, Nanda S, Nandal R (2015). "Lower Genital Tract Infections in HIV-Infected Women: Can We Afford to Miss?". J Obstet Gynaecol India. 65 (1): 45–9. doi:10.1007/s13224-014-0604-6. PMC 4342383. PMID 25737622.

Template:WS Template:WH